Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report
2009

Topiramate and Citalopram Linked to Acute Glaucoma in Migraine Patient

Sample size: 1 publication Evidence: low

Author Information

Author(s): Spaccapelo Luca, Leschiutta Silvia, Aurea Claudio, Ferrari Anna

Primary Institution: University of Modena and Reggio Emilia

Hypothesis

Can the concurrent use of topiramate and citalopram increase the risk of developing acute glaucoma?

Conclusion

The case suggests that both topiramate and citalopram may contribute to increased intraocular pressure and the development of glaucoma.

Supporting Evidence

  • Topiramate is known to cause acute glaucoma in some patients.
  • Citalopram has also been linked to increased intraocular pressure.
  • The patient developed symptoms of glaucoma shortly after starting topiramate.
  • Both medications can affect eye pressure, potentially leading to glaucoma.

Takeaway

A man taking topiramate for migraines and citalopram for depression developed serious eye problems, showing that these medications can affect eye pressure.

Methodology

Case report detailing the patient's treatment and subsequent development of glaucoma.

Limitations

Only one case is reported, limiting generalizability.

Participant Demographics

34 year-old male with a history of migraine and anxiety-depressive syndrome.

Digital Object Identifier (DOI)

10.1186/1757-1626-2-87

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication